Back to Search
Start Over
Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways.
- Source :
-
Oncogene [Oncogene] 2003 Mar 06; Vol. 22 (9), pp. 1281-93. - Publication Year :
- 2003
-
Abstract
- CC139 fibroblasts are one of several model systems in which the Raf --> MEK --> ERK1/2 pathway can inhibit apoptosis independently of the PI3K pathway; however, the precise mechanism for this protective effect is not known. Serum withdrawal from CC139 fibroblasts resulted in the rapid onset of apoptosis, which was prevented by actinomycin D or cycloheximide. Serum withdrawal promoted the rapid, de novo accumulation of Bim(EL), a proapoptotic 'BH3-only' member of the Bcl-2 protein family. Bim(EL) expression was an early event, occurring several hours prior to caspase activation. In contrast to studies in neurons, activation of the JNK --> c-Jun pathway was neither necessary nor sufficient to induce Bim(EL) expression. Selective inhibition of either the ERK pathway (with U0126) or the PI3K pathway (with LY294002) caused an increase in the expression of Bim(EL). Furthermore, selective activation of the ERK1/2 pathway by deltaRaf-1:ER* substantially reduced Bim(EL) expression, abolished conformational changes in Bax and blocked the appearance of apoptotic cells. The ability of deltaRaf-1:ER* to repress Bim(EL) expression required the ERK pathway but was independent of the PI3K --> PDK --> PKB pathway. Thus, serum withdrawal-induced expression of Bim(EL) occurs independently of the JNK --> c-Jun pathway and can be repressed by the ERK pathway independently of the PI3K pathway. This may contribute to Raf- and Ras-induced cell survival at low serum concentrations.
- Subjects :
- Animals
Apoptosis drug effects
Apoptosis Regulatory Proteins
Bcl-2-Like Protein 11
Butadienes pharmacology
Carrier Proteins genetics
Cell Line drug effects
Cell Line metabolism
Chromones pharmacology
Cricetinae
Cricetulus
Culture Media, Serum-Free pharmacology
Cycloheximide pharmacology
Cysteine Endopeptidases pharmacology
Cysteine Proteinase Inhibitors pharmacology
Dactinomycin pharmacology
Enzyme Activation drug effects
Enzyme Inhibitors pharmacology
Fibroblasts metabolism
JNK Mitogen-Activated Protein Kinases
Lung
Mitogen-Activated Protein Kinase 1 antagonists & inhibitors
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases antagonists & inhibitors
Morpholines pharmacology
Nitriles pharmacology
Nucleic Acid Synthesis Inhibitors pharmacology
Phosphoinositide-3 Kinase Inhibitors
Protein Serine-Threonine Kinases genetics
Protein Serine-Threonine Kinases metabolism
Protein Structure, Tertiary
Protein Synthesis Inhibitors pharmacology
Proto-Oncogene Proteins metabolism
Proto-Oncogene Proteins c-raf genetics
RNA, Messenger biosynthesis
RNA, Messenger genetics
Recombinant Fusion Proteins metabolism
Signal Transduction drug effects
Signal Transduction physiology
bcl-2-Associated X Protein
Carrier Proteins biosynthesis
Membrane Proteins
Mitogen-Activated Protein Kinase 1 metabolism
Mitogen-Activated Protein Kinases metabolism
Mitogen-Activated Protein Kinases physiology
Phosphatidylinositol 3-Kinases physiology
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-raf physiology
Subjects
Details
- Language :
- English
- ISSN :
- 0950-9232
- Volume :
- 22
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Oncogene
- Publication Type :
- Academic Journal
- Accession number :
- 12618753
- Full Text :
- https://doi.org/10.1038/sj.onc.1206261